Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].
The global Atomoxetine HCL API market is experiencing significant growth, driven by several key factors:
North America is expected to predominant the API market due to the significant healthcare expenditure projections. This dominance is expected to cause North America to account for around 40% of the global market[1].
Europe was initially included in the market due to the high prevalence of ADHD, but as generic alternatives like Stratteraoh CL, further waxing and brookface forms are being embraced for use in advanced patients. The region holds around 40% of the global drug market[1].
The Asia Pacific region is expected to be the largest demand chain, driven by the rising demand for prescription medications and expanding regional markets. The region's cGMP factors are also expected to influence the market. The Asia Pacific region is characterized by the rapid expansion of pharmaceutical companies,hips in large quantities, and substantial healthcare expenditure. This region is expected to grow at a CAGR of 4.0% from 2025 to 2031[1].
These demand chains are influenced by factors such as economic instability, changing demographics, and the challenging market complexion of Latin America. Latin America is a major demand chain, with major demand chains catering to high-income populations and Latin America's unique culture and demographics[1].
The rising incidence of ADHD is a significant driver of the market, as is the expanding prevalence of medications like Atomoxetine HCL. These increasing options are expected to provide patients with more effective treatments, contributing to its growth. However, the global Atomoxetine HCL API market is expected to grow at a CAGR of 4.0% from 2024 to 2031. This region is expected to do so around a CAGR of 4.0% and a CAGR/US product penetration at around 41%[1].
The increasing prevalence of ADHD is another key driver of the market, as Atomoxetine HCL is expected to contribute to its growth. As more patients take the medication, the demand for effective treatments is expected to rise, driving up the cost of the medication. This growing patientele is fueled by the increasing adoption of Atomoxetine HCL in advanced ADHD diagnoses. However, the global Atomoxetine HCL API market is also expected to grow at a CAGR of 4.0% from 2024 to 2031[1].
ADHD is a mental health condition that affects approximately 10% of the adult population in Australia.In children and adolescents, ADHD symptoms include:
Atomoxetine treatment is available over-the-counter (e.g., vitamins, behavioural and psychological medication, stimulant medication, etc.) as a prescription medication. It is a treatment option that has gained popularity in recent years due to its ease of use and relatively low cost. It is important to consult a healthcare professional for a thorough diagnosis and treatment plan.
Strattera belongs to a class of drugs known as 5-alpha-reductase inhibitors (5-ARIs). Strattera works by blocking the production of certain chemicals in the brain that influence attention, impulse control, and concentration. Strattera is usually prescribed for a short period of time in adults.
The key mechanism of action of Strattera is the inhibition of the norepinephrine transporter, which allows for increased levels of norepinephrine in the brain. This leads to increased activity of the norepinephrine transporter and enhanced synaptic availability of norepinephrine, which helps to improve attention and impulse control.
Strattera is also known to improve cognitive function in some individuals. Some studies have suggested that Strattera may improve executive functioning in people with dementia and ADHD, possibly by enhancing executive functioning, which is thought to be linked to executive functioning and executive skills.
The dosage of Strattera is based on the condition being treated, which is to be taken orally. The medication is usually taken once a day, ideally once a day with meals. It is important to follow the prescribed dosage and duration of treatment and not to change the dosage without consulting a doctor first. Strattera is usually taken once a day with meals. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. It is important to note that the amount of medication taken should only be used under the supervision of a healthcare professional, as it can cause adverse effects and should only be used under the advice of a healthcare provider.
The most common side effects of Strattera include:
Strattera should not be taken by children or adolescents under 18 years of age.
There are a number of other medications that can interact with Strattera.
Struggling with attention deficit disorder (ADHD)? Atomoxetine can help you get through this first step and stay organized.
Treating ADHD can help you stay focused, stay organized and have better control over your everyday lives.
Atomoxetine is a medication that belongs to a class of drugs called selective norepinephrine reuptake inhibitors. It is used to treat ADHD by increasing the levels of norepinephrine in the brain. It works by restoring the balance of certain chemicals in the brain.
You may have heard of Strattera before, but without any scientific research into its effectiveness or safety, this medication isn’t that effective. In this article, we will explore the similarities and differences between Atomoxetine and Strattera so that we can make an informed decision about its use for managing ADHD.
is a medication that helps to reduce feelings of restlessness and irritability in children and adults with ADHD. Atomoxetine works by increasing the levels of norepinephrine in the brain. This increase in norepinephrine can lead to a decreased appetite and a decreased sleep schedule.
Like other medications that increase norepinephrine levels, Strattera also works by increasing the levels of dopamine in the brain. Dopamine is a neurotransmitter that helps regulate mood, emotions and behavior. By increasing the levels of dopamine, Strattera can help to increase pleasure and reduce worry.
However, it’s important to note that Atomoxetine should only be taken under the guidance and supervision of a healthcare professional and not over the counter products sold by manufacturers. Always consult your healthcare provider to determine if Atomoxetine is the right choice for you.
Strattera and Atomoxetine are both medications that help to treat ADHD. They both work by increasing the levels of norepinephrine in the brain. However, they differ in several ways.
There are many conditions that can be treated with Strattera, but it’s important to talk to your doctor before starting any new medication. If you’re unsure about any of the conditions Treated with Strattera, a consultation with your doctor is necessary.
Generic name:Atomoxetine - oral
Pronunciation(atomoxetine-k)
Brand name(s)Strattera
Atomoxetine is used to treat depression, anxiety, and other conditions that may be caused by a lack of appetite or weight gain. It belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs). It works by changing the amount of norepinephrine (a neurotransmitter in the brain) that is available to nerve cells.
Read the Patient Information Leaflet if available from your pharmacist before you start taking Atomoxetine and each time you get a refill. If you have any questions, consult your doctor or pharmacist.
Take this medication by mouth as directed by your doctor, usually 2 to 4 times a day. The dosage is based on your medical condition and response to treatment.
The length of treatment is also important. Some types of treatment may last more than 6 months, while others may require treatment for not more than a few months. Children's treatment is also important for certain medical conditions.
If you are taking the capsules or tablets every day, your dosage will be based on your weight. Swallow the capsules whole with a drink of water. Do not crush or chew the capsules; talk to your pharmacist before using the medication.
Use this medication regularly in order to get the most benefit from it. To help you remember, take it at the same time each day.
Always follow your doctor's instructions when taking this medication. If you experience side effects, such as dizziness or fatigue, contact your doctor right away.
Take this medication regularly to maintain stable levels of its active ingredient in your body. Your doctor may monitor your weight and may also order tests to check your progress.
Tell your doctor if your condition lasts or gets worse.
To reduce the risk of side effects, continue taking this medication for the full course of treatment. If you experience skin rashes, severe dizziness, or fainting, stop taking this medication and contact your doctor immediately.
Common side effects of Atomoxetine include:
Serious side effects that may not be listed here are:
More information about side effects is in the patient information leaflet that your doctor has provided you may share with your doctor.
Serotonin syndrome is a rare condition that can affect the central nervous system. Symptoms include:
Symptoms of serotonin syndrome may include:
If you have any of these symptoms, it is important that you contact a doctor right away about it.
Although this medication is not approved for use in children, it is usually given to children between the ages of 10 and 17 years of age who are unable to swallow tablets, capsules, or oral suspension because the dosage may not be suitable for children under the age of 10 years.
This medication may be prescribed for other medical conditions, so tell your doctor or pharmacist if you are taking or have recently taken any other medications or are taking any prescription or nonprescription medicine, nutritional supplement, or dietary supplement.
The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Strattera-100-MG-Oral-Tablet
Atom: 513
Telmisartan + 513 is a combination of two medicines used to treat heart disease, which is a condition that causes chest pain and shortness of breath. If you are experiencing symptoms of heart disease or allergic reactions (such as trouble breathing or swallowing, swelling of the throat, or tightness or rupture of the throat), you need to see your doctor. The first step is to see that your doctor approves it. The second step is to take it as prescribed and to speak to your doctor. It can take up to 4 weeks for it to be effective, so if you stop taking it, it can cause withdrawal symptoms. If you have any questions, please talk to your doctor.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
QAR-24, 60 Capsules, 12 TabletAUSTRALia
SKUSTRATTERA24-OX-24-OX-6-TAB-PHARMACICUS/SPAN
EAN-2900-B10-V
Tripoli, 30, from Nagpur
Tripoli, 60, from Nagpur
AUSTRALia, 30, from Nagpur
The content on this page has been supplied to has been designed to be suitable for general medical and travel travel travel travel and is not intended to diagnose, treat, cure or prevent any disease. Always ensure you read the label before you start taking any medication and if you have any questions along with your allergies before starting your travel or travel-related activities. The content on this page should not be regarded as specific instructions or recommendations about travel or travel-related activities. Please consult your travel or travel-related professional and/or travel-related travel doctor's letter for more information.
Stade de France Pharmacy